Stable Intracerebral Transplantation of Neural Stem Cells for the Treatment of Paralysis Due to Ischemic Stroke

NSI‐566 is a stable, primary adherent neural stem cell line derived from a single human fetal spinal cord and expanded epigenetically with no genetic modification. This cell line is being tested in clinical trials in the U.S. for treatment of amyotrophic lateral sclerosis and spinal cord injury. In...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Stem Cells Transl Med
Autors principals: Zhang, Guangzhu, Li, Ying, Reuss, James L., Liu, Nan, Wu, Cuiying, Li, Jingpo, Xu, Shuangshuang, Wang, Feng, Hazel, Thomas G., Cunningham, Miles, Zhang, Hongtian, Dai, Yiwu, Hong, Peng, Zhang, Ping, He, Jianghong, Feng, Huiru, Lu, Xiangdong, Ulmer, John L., Johe, Karl K., Xu, Ruxiang
Format: Artigo
Idioma:Inglês
Publicat: John Wiley & Sons, Inc. 2019
Matèries:
Human Clinical Articles
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6766600/
https://ncbi.nlm.nih.gov/pubmed/31241246
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/sctm.18-0220
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars